Evidence map›Paper›PMID 36591511›Full record

ArticleFrontiers in oncology2022

Non-classical phenotypes of mismatch repair deficiency and microsatellite instability in primary and metastatic tumors at different sites in Lynch syndrome.

Zhiyu Li, Bo Cheng, Shan Liu, Shanshan Ding, Jinhong Liu, Lanju Quan, Yanjiao Hao, Lin Xu, Huan Zhao, Jing Guo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhiyu LiSchool of Basic Medicine, Hebei North University, Zhangjiakou, Hebei, China.
Bo ChengDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Shan LiuDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Shanshan DingDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Jinhong LiuDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Lanju QuanDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Yanjiao HaoSchool of Basic Medicine, Hebei North University, Zhangjiakou, Hebei, China.
Lin XuDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Huan ZhaoDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Jing GuoDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Suozhu SunDepartment of Pathology, Chinese People's Liberation Army (PLA) Rocket Force Specialized Medical Center, Beijing, China.
Chinese People's Liberation Army · CNHebei North University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lynch syndrome is a genetic disease characterized by abnormal DNA replication caused by germline variation in the mismatch repair (MMR) gene. There are rare non-classical phenotypes with loss of MMR protein expression and inconsistent microsatellite stability (MSS) in Lynch syndrome-related colorectal cancers. However, the difference between microsatellite instability (MSI) of extraintestinal tumors in a patient with Lynch syndrome has been closely studied. Herein, we reported the non-classical phenotypes of mismatch repair deficiency (dMMR) and MSI in four cases of Lynch syndrome in patients with colorectal cancer and other primary and metastatic tumors. Methods: A retrospective analysis was conducted on four patients diagnosed with Lynch syndrome between 2018 and 2022 in the Department of Pathology of the Rocket Forces Specialized Medical Center. A one-step immunohistochemical (IHC) assay was employed to detect loss in the expression of Lynch syndrome-associated MMR proteins (MLH1, PMS2, MSH2, and MSH6). MSI detection was performed in both primary and metastatic tumors at different sites in the four patients using NCI 2B3D (BAT25, BAT26, D2S123, D17S250, and D5S346) and single nucleotide site (BAT25, BAT26, NR21, NR24, NR27, and MONO27) methods. In addition, related MMR gene germline variation, somatic mutations, and Results: Two of the four patients were heterozygous for Conclusions: The non-classical dMMR and MSI phenotype are mostly observed in Lynch syndrome, even in the context of MMR protein expression loss. Extraintestinal tumors infrequently present with a high degree of MSI and often exhibit a stable or low degree of MSI.

Indexed as

colorectal cancerheterogeneityLynch syndromemicrosatellite instabilitymismatch repair protein

Identifiers

PMID36591511
PMCPMC9797996
OpenAlexW4311510642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.